Telomere shortening and telomerase reactivation in dysplastic nodules of human hepatocarcinogenesis - PubMed (original) (raw)
Telomere shortening and telomerase reactivation in dysplastic nodules of human hepatocarcinogenesis
Bong-Kyeong Oh et al. J Hepatol. 2003 Nov.
Abstract
Backgrounds/aims: The maintenance of telomere with telomerase reactivation, vital for carcinogenesis, was studied in human multistep hepatocarcinogenesis for the characterization of borderline lesions.
Methods: The terminal restriction fragment length (TRFL) and telomerase activity (TA) were examined in 3 chronic hepatitis (CH), 10 cirrhosis, 7 large regenerative nodules (LRNs), 30 low grade dysplastic nodules (LGDNs), 6 high grade DNs (HGDNs), 3 DNs with hepatocellular carcinoma (HCC) foci, 11 HCCs, and 4 normal livers by Southern hybridization and TRAPeze Elisa telomerase detection.
Results: The TRFL and TA showed significant differences between the LGDNs and HGDNs. Most LGDNs had similar levels of TRFL and TA to those of the CH, cirrhosis and LRNs, however, 17% of LGDNs revealed shortening of telomeres up to the levels of HGDNs and 7% of LGDNs showed high levels of TA. The levels of TRFL and TA in HGDNs showed no significant differences from those of DNs with HCC foci and HCCs.
Conclusions: The shortening of telomeres and reactivation of telomerase occur in the DNs during the early stages of hepatocarcinogenesis, with a significant change in the transition of LGDNs to HGDNs. The characteristics of HGDNs are considered to be closer to those of HCCs.
Similar articles
- An early lesion in hepatic carcinogenesis: loss of heterozygosity in human cirrhotic livers and dysplastic nodules at the 1p36-p34 region.
Sun M, Eshleman JR, Ferrell LD, Jacobs G, Sudilovsky EC, Tuthill R, Hussein MR, Sudilovsky O. Sun M, et al. Hepatology. 2001 Jun;33(6):1415-24. doi: 10.1053/jhep.2001.24751. Hepatology. 2001. PMID: 11391530 - Quantitative assessment of hTERT mRNA expression in dysplastic nodules of HBV-related hepatocarcinogenesis.
Oh BK, Kim YJ, Park YN, Choi J, Kim KS, Park C. Oh BK, et al. Am J Gastroenterol. 2006 Apr;101(4):831-8. doi: 10.1111/j.1572-0241.2006.00532.x. Epub 2006 Feb 22. Am J Gastroenterol. 2006. PMID: 16494581 - Progressive telomere shortening and telomerase reactivation during hepatocellular carcinogenesis.
Miura N, Horikawa I, Nishimoto A, Ohmura H, Ito H, Hirohashi S, Shay JW, Oshimura M. Miura N, et al. Cancer Genet Cytogenet. 1997 Jan;93(1):56-62. doi: 10.1016/s0165-4608(96)00329-9. Cancer Genet Cytogenet. 1997. PMID: 9062581 - Preneoplastic lesions in human hepatocarcinogenesis.
Libbrecht L, Desmet V, Roskams T. Libbrecht L, et al. Liver Int. 2005 Feb;25(1):16-27. doi: 10.1111/j.1478-3231.2005.01016.x. Liver Int. 2005. PMID: 15698394 Review. - The role of telomeres and telomerase in cirrhosis and liver cancer.
Nault JC, Ningarhari M, Rebouissou S, Zucman-Rossi J. Nault JC, et al. Nat Rev Gastroenterol Hepatol. 2019 Sep;16(9):544-558. doi: 10.1038/s41575-019-0165-3. Epub 2019 Jun 28. Nat Rev Gastroenterol Hepatol. 2019. PMID: 31253940 Review.
Cited by
- Increased amounts and stability of telomeric repeat-containing RNA (TERRA) following DNA damage induced by etoposide.
Oh BK, Choi Y, Bae J, Lee WM, Hoh JK, Choi JS. Oh BK, et al. PLoS One. 2019 Nov 22;14(11):e0225302. doi: 10.1371/journal.pone.0225302. eCollection 2019. PLoS One. 2019. PMID: 31756221 Free PMC article. - Cellular Genomic Sites of Hepatitis B Virus DNA Integration.
Budzinska MA, Shackel NA, Urban S, Tu T. Budzinska MA, et al. Genes (Basel). 2018 Jul 20;9(7):365. doi: 10.3390/genes9070365. Genes (Basel). 2018. PMID: 30037029 Free PMC article. Review. - Telomere length variation in tumor cells and cancer-associated fibroblasts: potential biomarker for hepatocellular carcinoma.
Ma LJ, Wang XY, Duan M, Liu LZ, Shi JY, Dong LQ, Yang LX, Wang ZC, Ding ZB, Ke AW, Cao Y, Zhang XM, Zhou J, Fan J, Gao Q. Ma LJ, et al. J Pathol. 2017 Dec;243(4):407-417. doi: 10.1002/path.4961. Epub 2017 Oct 13. J Pathol. 2017. PMID: 28833123 Free PMC article. - Telomere Length and Risk of Hepatocellular Carcinoma: A Nested Case-control Study in Taiwan Cancer Screening Program Cohort.
Zeng H, Wu HC, Wang Q, Yang HI, Chen CJ, Santella RM, Shen J. Zeng H, et al. Anticancer Res. 2017 Feb;37(2):637-644. doi: 10.21873/anticanres.11358. Anticancer Res. 2017. PMID: 28179311 Free PMC article. - Telomere Length and Survival of Patients with Hepatocellular Carcinoma in the United States.
Yang B, Shebl FM, Sternberg LR, Warner AC, Kleiner DE, Edelman DC, Gomez A, Dagnall CL, Hicks BD, Altekruse SF, Hernandez BY, Lynch CF, Meltzer PS, McGlynn KA. Yang B, et al. PLoS One. 2016 Nov 23;11(11):e0166828. doi: 10.1371/journal.pone.0166828. eCollection 2016. PLoS One. 2016. PMID: 27880792 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical